Change the keyword or sentiment above, then click Apply.
Friday, 11 Sep 20261 update
↔ AI sentiment: Neutral
90% confidence
Bafna Pharma Reviews FY26, Plans at AGM
Bafna Pharmaceuticals held its 31st AGM on Sept 11, 2026 via VC/OAVM, discussing FY 2025-26 performance.
Key agenda included financial statements, director reappointment, and auditor remuneration ratification.
Source: BSE